Meeting 46, 20223-03-17

Abstract: The rise of high throughput molecular technologies has shed lights on the development of next-generation molecular diagnostics and biomarkers for patient stratifications in the precision medicine era. There is an urgent need to develop new systematic tools to combine multi-omics data and link genotype to phenotype to expand our knowledge of complex traits of human diseases. Our research mainly focuses on the integration of multi-omics, the interplay between genetics and phenotypes, and the development of data-driven strategies/tools for precision medicine. The aim is to investigate the molecular biomarkers for the estimation of disease risks, early diagnosis of disease, stratification of drug treatment response, disease progression monitoring and the stratification of patients. To enable these projects, we develop and optimize integrative multi-omics methods to facilitate the utilization of data-driven systems medicine and inform precision medicine-based decision support.

Presentation: TBA (after session)